GSK plc vs McDonald's Corp — how do they compare? GSK plc trades at $50.5 (market cap $102.60B), while McDonald's Corp trades at $274.06 (market cap $194.00B). The key difference: McDonald's Corp is the larger of the two by market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | MCD | |
|---|---|---|
Market Cap | $102.60B | $194.00B |
Sector | Health | Consumer Cyclical |
52-Week High | $61.18 | $341.06 |
52-Week Low | $38.22 | $262.80 |
Enterprise Value | $123.04B | $247.77B |
Dividend Yield | 3.57% | 2.71% |
Volume | — | 2,230,036 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
McDonald's (MCD) trades at $273.72, down 0.28% on the day, with a neutral technical signal and strong fundamentals including a 31.72% net margin and consistent earnings beats. The company recently unveiled its 'McDonald's NEXT' growth strategy focusing on automation and menu innovation to drive future performance. Revenue growth remains steady, with 2025 revenue at $26.89 billion.
Outlook is positive with a consensus price target of $322.45 offering 17.8% upside, supported by 60% analyst buy ratings. Risks include inflationary pressures on franchisee margins and high long-term debt of $38.42 billion. The stock presents a value opportunity with stable dividends and strategic initiatives aimed at enhancing competitiveness.
Trailing returns across standard periods
Latest headlines on both assets
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Read more on MCD →